Unilever (NYSE:UL) Earns Buy (B) Rating from Weiss Ratings

Key Points

• Unilever has received a "buy (B)" rating from Weiss Ratings, indicating positive sentiment among equities research analysts about the stock's potential.
• The stock remains under varied ratings from different analysts, with the current consensus being a "Moderate Buy" and a price target of $73.00.
• As of the latest trading data, Unilever's shares are priced at $62.60, showing a market capitalization of $153.58 billion.

Unilever (NYSE:UL - Get Free Report)'s stock had its "buy (b)" rating restated by equities research analysts at Weiss Ratings in a research note issued to investors on Friday,Weiss Ratings reports.

Several other research analysts have also weighed in on the stock. CICC Research began coverage on shares of Unilever in a research note on Thursday, August 21st. They set an "outperform" rating on the stock. Jefferies Financial Group restated an "underperform" rating on shares of Unilever in a research report on Sunday, August 3rd. Finally, Zacks Research downgraded shares of Unilever from a "strong-buy" rating to a "hold" rating in a report on Thursday, October 16th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $73.00.

Unilever Trading Up 0.4%

Shares of Unilever stock traded up $0.28 during trading on Friday, hitting $62.60. 1,977,963 shares of the stock were exchanged, compared to its average volume of 2,563,290. The stock has a market capitalization of $153.58 billion, a price-to-earnings ratio of 17.93, a price-to-earnings-growth ratio of 4.68 and a beta of 0.40. The company has a fifty day moving average price of $61.58 and a 200-day moving average price of $61.75. Unilever has a 1-year low of $54.32 and a 1-year high of $65.66.

Institutional Investors Weigh In On Unilever

Several hedge funds and other institutional investors have recently bought and sold shares of UL. Brighton Jones LLC grew its holdings in shares of Unilever by 5.4% during the fourth quarter. Brighton Jones LLC now owns 10,572 shares of the company's stock valued at $599,000 after buying an additional 539 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Unilever by 24.0% during the first quarter. GAMMA Investing LLC now owns 13,127 shares of the company's stock valued at $782,000 after buying an additional 2,544 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Unilever by 0.8% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 87,674 shares of the company's stock valued at $5,221,000 after buying an additional 731 shares during the last quarter. Spire Wealth Management grew its holdings in shares of Unilever by 3.6% during the first quarter. Spire Wealth Management now owns 16,063 shares of the company's stock valued at $957,000 after buying an additional 553 shares during the last quarter. Finally, Bessemer Group Inc. grew its holdings in shares of Unilever by 164.6% during the first quarter. Bessemer Group Inc. now owns 6,638 shares of the company's stock valued at $395,000 after buying an additional 4,129 shares during the last quarter. 9.67% of the stock is owned by institutional investors.

About Unilever

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.